Ethical Concerns Arise: Nestlé Accused of Adding Sugar and Honey to Infant Formula and Breakfast Cereals in Low-Income Countries

▴ Nestlé Accused of Adding Sugar and Honey
In India all cerelac baby cereal products examined by Public eye contained added sugar upto 3 gm per serving.

In recent news, a report by Public Eye and IBFAN has highlighted concerns about Nestlé adding sugar and honey to certain infant-formula and breakfast cereal products sold in lower-income countries, contrasting with practices in Europe. This issue raises ethical and public health questions, especially regarding the impact on vulnerable populations in regions where obesity rates are rising.

Nestlé’s Sugar Addition in Infant Products: According to the report, an analysis of 150 Nestlé products in lower-income countries revealed that nearly all Cerelac-branded infant cereals contained added sugar, averaging around four grams per serving. In some countries like the Philippines, this figure was as high as 7.3 grams. Moreover, in India, all cerelac baby cereal products contained added sugar upto 3 gm per serving. Similarly, Nido powdered milks showed significant added sugar content, with up to two grams per serving identified in most products, reaching 5.3 grams in certain cases in Panama.

The report contrasts this practice with Nestlé’s products in Europe, where similar items are sold without added sugar. This disparity has raised concerns among paediatricians and child nutrition experts, who argue that such practices exploit weaker regulations in certain regions, contributing to health challenges like childhood obesity.

Nestlé’s Response and Actions: In response to these claims, Nestlé defended its practices, emphasizing that it adheres to local regulations and international standards across its operations. The company stated that it has reduced added sugars in its infant cereals portfolio by 11% over the past decade, aiming to balance nutrition, safety, and taste in its products.
Nestlé promotes Cerelac as a nutritious option for infants aged six months and older, highlighting its availability in various countries, including Belgium, Portugal, India, South Africa, and the Philippines. The Nido range is positioned as a trusted brand for childhood nutrition, tailored to different stages of development.

Criticism of Marketing Strategies: Public Eye and IBFAN criticized Nestlé’s marketing strategies, alleging the use of misleading tactics to gain parents trust in its products. They expressed concerns about the involvement of medical professionals and social media influencers in promoting Nestlé’s infant products.

Call for Change and Petition: In response to these findings, Public Eye and IBFAN have launched a petition urging Nestlé to stop adding sugar to products intended for babies and young children globally. They advocate for greater transparency and adherence to WHO recommendations on sugar content in baby foods.

WHO’s Perspective: Nigel Rollins from the World Health Organization (WHO) weighed in on the issue, highlighting the ethical and public health implications of Nestlé’s sugar practices. He emphasized the need for consistent standards in product formulation, especially concerning vulnerable populations.

Reformulation and Transparency: Nestlé responded by reaffirming its commitment to reducing added sugars in infant-cereal products without compromising quality. The company mentioned ongoing efforts to phase out added sugars from its Nido growing up milks globally, aligning with evolving nutritional guidelines. While variations in product recipes exist across countries due to regulatory factors and ingredient availability, Nestlé emphasized that these variations do not compromise product quality.

The debate over sugar in Nestlé’s infant products exposes broader concerns about nutrition, health, and corporate responsibility. The call for transparency, adherence to global health guidelines, and equitable practices in product formulation highlights the importance of ensuring the well-being of infants and young children, regardless of geographic location or socio-economic status. As stakeholders continue to advocate for change, the focus remains on promoting healthier options and fostering greater accountability in the infant nutrition industry.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sanmarg Auto++: Revolutionizing Mobility at Kolkata’s Biggest Auto FairMarch 22, 2025
39th Prof. M. Viswanathan Oration Highlights Strategies to Prevent Diabetic Foot AmputationsMarch 22, 2025
Catapulting funding crisis into opportunity by getting on track to end TB and tobacco useMarch 22, 2025
University of Leeds Opens Applications for MSc in Sustainable Agriculture & Food Production for Indian StudentsMarch 21, 2025
Crompton Reimagines Lighting with Launch of INFINIA - 20% Extra Brightness & SlimO - Ultra-Sleek Appeal!March 21, 2025
March 21, 2025
World Down Syndrome Day: Why India is Still Failing Its Special ChildrenMarch 21, 2025
The Digital Delusion: How Social Media Is Rewiring Your RealityMarch 21, 2025
Can Giving Blood Lower Your Risk of Heart Disease and Diabetes? Find OutMarch 21, 2025
Embracing Extra Chromosomes: Individuals with Down Syndrome face health challenges, stigma, and limited care, but early intervention and inclusion can transform their livesMarch 20, 2025
Why Doctors May Soon Prescribe Walks in the Park Instead of PillsMarch 20, 2025
Today some of the LIC agents met the Hon’ble Leader of Opposition and raised certain issues.March 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Think Alcohol Is Bad for You? New Research Might Prove You WrongMarch 20, 2025
Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetesMarch 20, 2025
How can we leave those behind who are at higher TB risk?March 20, 2025
The Global Tuberculosis Fight: Why Prevention Holds Key to EradicationMarch 20, 2025
Chew Your Way to a Sharper Mind: The Surprising Brain Hack No One Told You AboutMarch 20, 2025
Danger of substandard and falsified medical products is real and growingMarch 19, 2025